spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search    

The fully linked HTML version of this article has now been published.
JCS ePress online publication date 12 Feb 2003
doi: 10.1242/jcs.00331

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.00331v1
116/7/1349    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davis, T.
Right arrow Articles by Kipling, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, T.
Right arrow Articles by Kipling, D.

Research Article

Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms


Terence Davis, Sim K. Singhrao, Fiona S. Wyllie, Michele F. Haughton, Paul J. Smith, Marie Wiltshire, David Wynford-Thomas, Christopher J. Jones, Richard G.A. Faragher, and David Kipling*
* Author for correspondence (e-mail: kiplingd{at}cardiff.ac.uk)

Werner-syndrome fibroblasts have a reduced in vitro life span before entering replicative senescence. Although this has been thought to be causal in the accelerated ageing of this disease, controversy remains as to whether Werner syndrome is showing the acceleration of a normal cellular ageing mechanism or the occurrence of a novel Werner-syndrome-specific process. Here, we analyse the signalling pathways responsible for senescence in Werner-syndrome fibroblasts. Cultured Werner-syndrome (AG05229) fibroblasts senesced after ~20 population doublings with most of the cells having a 2N content of DNA. This was associated with hypophosphorylated pRb and high levels of p16Ink4a and p21Waf1. Senescent AG05229 cells re-entered the cell cycle following microinjection of a p53-neutralizing antibody. Similarly, production of the human papilloma virus 16 E6 oncoprotein in presenescent AG05229 cells resulted in senescence being bypassed and extended cellular life span. Werner-syndrome fibroblasts expressing E6 did not proliferate indefinitely but reached a second proliferative lifespan barrier, termed Mint, that could be bypassed by forced production of telomerase in post-M1 E6-producing cells. The conclusions from these studies are that: (1) replicative senescence in Werner-syndrome fibroblasts is a telomere-induced p53-dependent event; and (2) the intermediate lifespan barrier Mint is also a telomere-induced event, although it appears to be independent of p53. Werner-syndrome fibroblasts resemble normal human fibroblasts for both these proliferative lifespan barriers, with the strong similarity between the signalling pathway linking telomeres to cell-cycle arrest in Werner-syndrome and normal fibroblasts providing further support for the defect in Werner syndrome causing the acceleration of a normal ageing mechanism.


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
R. M. Brosh Jr and V. A. Bohr
Human premature aging, DNA repair and RecQ helicases
Nucleic Acids Res., December 3, 2007; 35(22): 7527 - 7544.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Sharma, D. J. Stumpo, A. S. Balajee, C. B. Bock, P. M. Lansdorp, R. M. Brosh Jr., and P. J. Blackshear
RECQL, a Member of the RecQ Family of DNA Helicases, Suppresses Chromosomal Instability
Mol. Cell. Biol., March 1, 2007; 27(5): 1784 - 1794.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. S. Eller, X. Liao, S. Liu, K. Hanna, H. Backvall, P. L. Opresko, V. A. Bohr, and B. A. Gilchrest
A role for WRN in telomere-based DNA damage responses
PNAS, October 10, 2006; 103(41): 15073 - 15078.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
T. Davis, D. M. Baird, M. F. Haughton, C. J. Jones, and D. Kipling
Prevention of Accelerated Cell Aging in Werner Syndrome Using a p38 Mitogen-Activated Protein Kinase Inhibitor
J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2005; 60(11): 1386 - 1393.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
K. Hardy, L. Mansfield, A. Mackay, S. Benvenuti, S. Ismail, P. Arora, M. J. O'Hare, and P. S. Jat
Transcriptional Networks and Cellular Senescence in Human Mammary Fibroblasts
Mol. Biol. Cell, February 1, 2005; 16(2): 943 - 953.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
D. Kipling, T. Davis, E. L. Ostler, and R. G. A. Faragher
What Can Progeroid Syndromes Tell Us About Human Aging?
Science, September 3, 2004; 305(5689): 1426 - 1431.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. J. Kyng, A. May, S. Kolvraa, and V. A. Bohr
Gene expression profiling in Werner syndrome closely resembles that of normal aging
PNAS, October 14, 2003; 100(21): 12259 - 12264.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. J. Evans, F. S. Wyllie, D. Wynford-Thomas, D. Kipling, and C. J. Jones
A P53-dependent, Telomere-independent Proliferative Life Span Barrier in Human Astrocytes Consistent with the Molecular Genetics of Glioma Development
Cancer Res., August 15, 2003; 63(16): 4854 - 4861.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 2003